Skip to main content
deisseroth-karl-2017

Karl Deisseroth was awarded the Dr. A.H. Heineken Prize for Medicine from the Royal Netherlands Academy of Arts and Sciences. 
Steve Fisch

News

Medical Research June 03, 2020

Karl Deisseroth wins 2020 Heineken Prize for Medicine

By Bruce Goldman

Karl Deisseroth was awarded the prize for developing optogenetics, which enables remote manipulation of nerve cells using light, and hydrogel-tissue chemistry, which lets light and molecular probes travel through biological tissue

The Royal Netherlands Academy of Arts and Sciences has awarded Karl Deisseroth, MD, PhD, professor of bioengineering and of psychiatry and behavioral sciences, its 2020 Dr. A.H. Heineken Prize for Medicine

The $200,000 prize is given biennially, in recognition of pioneering work in medicine, to a researcher whose achievements have led or are expected to lead to an important application in medical practice.

Medicine is one of five science categories for which the prize is awarded. The prizes are the Netherlands' most prestigious awards in the arts and sciences. Recipients are chosen by an international jury of distinguished scientists.

Deisseroth is receiving the Heineken Prize for developing two technologies: optogenetics, which enables researchers to use light to influence the activity of nerve cells, and hydrogel-tissue chemistry, which renders biological tissue accessible to light and molecular probes. Both discoveries play an important role in current brain research.

 "I'm honored to have shared this long and exciting journey with my amazingly talented students, postdoctoral fellows, staff and collaborators," said Deisseroth, who is also the D.H. Chen Professor and a Howard Hughes Medical Institute investigator. "It took many years for us to develop optogenetics in the lab - as with hydrogel-tissue chemistry - and it is a great message for the prize in medicine to be awarded for long-term basic-science discovery." 

About Stanford Medicine

Stanford Medicine is an integrated academic health system comprising the Stanford School of Medicine and adult and pediatric health care delivery systems. Together, they harness the full potential of biomedicine through collaborative research, education and clinical care for patients. For more information, please visit med.stanford.edu.

Senior science writer

Bruce Goldman

Bruce Goldman, MS, is a senior science writer in the Office of Communications. He covers immunology, infectious disease, transplantation, neurosciences, neurosurgery, bioengineering, molecular and cellular physiology, and biochemistry. A recovering philosophy major from the University of Wisconsin, he’s done his best to cover his tracks by obtaining yet another bachelor’s degree, this time in engineering physics from the University of Colorado, and attending finishing school, in cell biology, at Harvard University, where he received an award for his teaching of an undergraduate biology course. Articles he has written while at Stanford Medicine have won well over a dozen awards from the Association of American Medical Colleges and the Council for Advancement and Support of Education. He is a member of the National Association of Science Writers and the co-author of two books about the future: 2020 Visions: Long View of a Changing World (Portable Stanford) and Fast Forward (Harper). Once upon a time, he drove a car to Afghanistan. He can play guitar with his toes, but only while fast asleep and dreaming.